AAAAAA
Results: 1-25/28
Authors:
SCHENTAG JJ
STRENKOSKINIX LC
NIX DE
FORREST A
Citation: Jj. Schentag et al., PHARMACODYNAMIC INTERACTIONS OF ANTIBIOTICS ALONE AND IN COMBINATION, Clinical infectious diseases, 27(1), 1998, pp. 40-46
Authors:
NIX DE
Citation: De. Nix, INTRAPULMONARY CONCENTRATIONS OF ANTIMICROBIAL AGENTS, Infectious disease clinics of North America, 12(3), 1998, pp. 631
Authors:
PELOQUIN CA
BULPITT AE
JARESKO GS
JELLIFFE RW
JAMES GT
NIX DE
Citation: Ca. Peloquin et al., PHARMACOKINETICS OF PYRAZINAMIDE UNDER FASTING CONDITIONS, WITH FOOD,AND WITH ANTACIDS, Pharmacotherapy, 18(6), 1998, pp. 1205-1211
Authors:
STRENKOSKINIX LC
FORREST A
SCHENTAG JJ
NIX DE
Citation: Lc. Strenkoskinix et al., PHARMACODYNAMIC INTERACTIONS OF CIPROFLOXACIN, PIPERACILLIN, AND PIPERACILLIN TAZOBACTAM IN HEALTHY-VOLUNTEERS/, Journal of clinical pharmacology, 38(11), 1998, pp. 1063-1071
Authors:
NIX DE
THOMAS JK
SYMONDS WT
SPIVEY JM
WILTON JH
GAGLIARDI NC
SCHENTAG JJ
Citation: De. Nix et al., ASSESSMENT OF THE ENZYMURIA RESULTING FROM GENTAMICIN ALONE AND COMBINATIONS OF GENTAMICIN WITH VARIOUS BETA-LACTAM ANTIBIOTICS, The Annals of pharmacotherapy, 31(6), 1997, pp. 696-703
Authors:
NIX DE
SYMONDS WT
HYATT JM
WILTON JH
TEAL MA
REIDENBERG P
AFFRIME MB
Citation: De. Nix et al., COMPARATIVE PHARMACOKINETICS OF ORAL CEFTIBUTEN, CEFIXIME, CEFACLOR, AND CEFUROXIME AXETIL IN HEALTHY-VOLUNTEERS, Pharmacotherapy, 17(1), 1997, pp. 121-125
Authors:
NIX DE
WILTON JH
HYATT J
THOMAS J
STRENKOSKINIX LC
FORREST A
SCHENTAG JJ
Citation: De. Nix et al., PHARMACODYNAMIC MODELING OF THE IN-VIVO INTERACTION BETWEEN CEFOTAXIME AND OFLOXACIN BY USING SERUM ULTRAFILTRATE INHIBITORY TITERS, Antimicrobial agents and chemotherapy, 41(5), 1997, pp. 1108-1114
Authors:
LI RC
NIX DE
SCHENTAG JJ
Citation: Rc. Li et al., PERFORMANCE OF THE FRACTIONAL MAXIMAL EFFECT METHOD - COMPARATIVE INTERACTION STUDIES OF CIPROFLOXACIN AND PROTEIN-SYNTHESIS INHIBITORS, Journal of chemotherapy, 8(1), 1996, pp. 25-32
Authors:
SCHENTAG JJ
NIX DE
FORREST A
ADELMAN MH
Citation: Jj. Schentag et al., AUIC - THE UNIVERSAL PARAMETER WITHIN THE CONSTRAINT OF A REASONABLE DOSING INTERVAL, The Annals of pharmacotherapy, 30(9), 1996, pp. 1029-1031
Authors:
KHALIG SL
NIX DE
JUSKO WJ
KOTAS T
Citation: Sl. Khalig et al., EFFECT OF METHYLPREDNISOLONE (MP) ON ENDOTOXIN-INDUCED TNF-ALPHA PRODUCTION IN WHOLE-BLOOD, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 19-19
Authors:
NIX DE
SCHENTAG JJ
Citation: De. Nix et Jj. Schentag, ROLE OF PHARMACOKINETICS AND PHARMACODYNAMICS IN THE DESIGN OF DOSAGESCHEDULES FOR 12-H CEFOTAXIME ALONE AND IN COMBINATION WITH OTHER ANTIBIOTICS, Diagnostic microbiology and infectious disease, 22(1-2), 1995, pp. 71-76
Authors:
TENG RL
HARRIS SC
NIX DE
SCHENTAG JJ
FOULDS G
LISTON TE
Citation: Rl. Teng et al., PHARMACOKINETICS AND SAFETY OF TROVAFLOXACIN (CP-99,219), A NEW QUINOLONE ANTIBIOTIC, FOLLOWING ADMINISTRATION OF SINGLE ORAL DOSES TO HEALTHY MALE-VOLUNTEERS, Journal of antimicrobial chemotherapy, 36(2), 1995, pp. 385-394
Authors:
KAZIERAD DJ
WOJCIK GJ
NIX DE
GOLDFARB AL
SCHENTAG JJ
Citation: Dj. Kazierad et al., THE EFFECT OF VERAPAMIL ON THE NEPHROTOXIC POTENTIAL OF GENTAMICIN ASMEASURED BY URINARY ENZYME EXCRETION IN HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 35(2), 1995, pp. 196-201
Authors:
OH YK
NIX DE
STRAUBINGER RM
Citation: Yk. Oh et al., FORMULATION AND EFFICACY OF LIPOSOME-ENCAPSULATED ANTIBIOTICS FOR THERAPY OF INTRACELLULAR MYCOBACTERIUM-AVIUM INFECTION, Antimicrobial agents and chemotherapy, 39(9), 1995, pp. 2104-2111
Authors:
HYATT JM
NIX DE
STRATTON CW
SCHENTAG JJ
Citation: Jm. Hyatt et al., IN-VITRO PHARMACODYNAMICS OF PIPERACILLIN, PIPERACILLIN-TAZOBACTAM, AND CIPROFLOXACIN ALONE AND IN COMBINATION AGAINST STAPHYLOCOCCUS-AUREUS, KLEBSIELLA-PNEUMONIAE, ENTEROBACTER-CLOACAE, AND PSEUDOMONAS-AERUGINOSA, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1711-1716
Authors:
NIX DE
TYRRELL R
MULLER M
Citation: De. Nix et al., PHARMACODYNAMICS OF METRONIDAZOLE DETERMINED BY A TIME-KILL ASSAY FORTRICHOMONAS-VAGINALIS, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1848-1852
Authors:
HYATT JM
FORREST A
NIX DE
Citation: Jm. Hyatt et al., PD MODELING OF BACTERIAL RATE OF KILL, IN-VITRO, FOR MONO AND COMBINATION THERAPY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 157-157
Authors:
GOSS TF
FORREST A
NIX DE
BALLOW CH
BIRMINGHAM MC
CUMBO TJ
SCHENTAG JJ
Citation: Tf. Goss et al., MATHEMATICAL EXAMINATION OF DUAL INDIVIDUALIZATION PRINCIPLES .2. THERATE OF BACTERIAL ERADICATION AT THE SAME AREA UNDER THE INHIBITORY CURVE IS MORE RAPID FOR CIPROFLOXACIN THAN FOR CEFMENOXIME, The Annals of pharmacotherapy, 28(7-8), 1994, pp. 863-868
Authors:
LI RC
NIX DE
SCHENTAG JJ
Citation: Rc. Li et al., INTERACTION BETWEEN CIPROFLOXACIN AND METAL-CATIONS - ITS INFLUENCE ON PHYSICOCHEMICAL CHARACTERISTICS AND ANTIBACTERIAL ACTIVITY, Pharmaceutical research, 11(6), 1994, pp. 917-920
Authors:
HYATT JM
NIX DE
SCHENTAG JJ
Citation: Jm. Hyatt et al., PHARMACOKINETIC AND PHARMACODYNAMIC ACTIVITIES OF CIPROFLOXACIN AGAINST STRAINS OF STREPTOCOCCUS-PNEUMONIAE, STAPHYLOCOCCUS-AUREUS, AND PSEUDOMONAS-AERUGINOSA FOR WHICH MICS ARE SIMILAR, Antimicrobial agents and chemotherapy, 38(12), 1994, pp. 2730-2737
Authors:
LI RC
NIX DE
SCHENTAG JJ
Citation: Rc. Li et al., PHARMACODYNAMIC MODELING OF BACTERIAL KINETICS - BETA-LACTAM ANTIBIOTICS AGAINST ESCHERICHIA-COLI, Journal of pharmaceutical sciences, 83(7), 1994, pp. 970-975
Authors:
HUH K
WILTON JH
NIX DE
SCHENTAG JJ
Citation: K. Huh et al., STRUCTURES AND BIOLOGICAL-ACTIVITIES OF TOBRAMYCIN-TICARCILLIN ADDUCTS, Journal of pharmaceutical sciences, 83(6), 1994, pp. 763-767
Authors:
NIX DE
SYMONDS WT
WILTON JH
REIDENBERG P
TEAL MA
OCONNOR G
SCHENTAG JJ
Citation: De. Nix et al., COMPARATIVE PHARMACOKINETICS OF ORAL CEFTIBUTEN, CEFIXIME, CEFACLOR, AND CEFUROXIME AXETIL IN NORMAL ADULTS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 192-192
Authors:
STRENKOSKI LC
NIX DE
Citation: Lc. Strenkoski et De. Nix, CEFPIROME CLINICAL PHARMACOKINETICS, Clinical pharmacokinetics, 25(4), 1993, pp. 263-273
Authors:
BIRMINGHAM MC
NIX DE
CUMBO TJ
COLLINS DA
WELS PB
SCHENTAG JJ
Citation: Mc. Birmingham et al., THE DEVELOPMENT OF A BEDSIDE ALGORITHM CAPABLE OF TARGETING ANTI-ENDOTOXINS TO THE RESPONDER SUBPOPULATIONS, Therapeutic drug monitoring, 15(6), 1993, pp. 503-509